IB Acquisition Corp. — Form 8-K Summary
Reporting date: March 29, 2024; earliest reported events occurred March 25 and March 28, 2024. IB Acquisition Corp. is a Nevada special purpose acquisition company (SPAC) and an emerging growth company. The filing primarily reports completion of its initial public offering and related financing and governance actions.
Business Context and Reporting Period
- On March 28, 2024, the company completed its IPO of 11,500,000 units, including the full exercise of the underwriters’ 1,500,000-unit over-allotment option.
- Each unit was sold for $10.00 and consists of one common share and one right. Each right entitles its holder to one-twentieth of one common share.
- The company’s securities trade on Nasdaq under the symbols IBACU, IBAC, and IBACR.
Financial Metrics, Capitalization, and Liquidity
| Metric | Amount or Description |
|---|---|
| IPO units issued | 11,500,000 |
| IPO gross proceeds | $115.0 million |
| Private placement units | 610,500 units sold to I-B Good Works 4, LLC |
| Private placement gross proceeds | $6.105 million |
| Total proceeds placed in trust | $115.575 million |
| Operating revenue and profit | The filing does not provide operating revenue, net income, earnings per share, or margin information. |
| Cash flow and debt | The filing does not provide cash-flow statements or debt balances. |
The IPO and private placement proceeds were deposited into a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company. Except for permitted interest used to pay taxes, the funds generally remain restricted until the initial business combination, specified shareholder redemptions, or the company’s failure to complete a business combination within 18 months of the IPO closing.
Material Changes Versus the Prior Comparable Period
- This filing reports the company’s transition from a pre-IPO entity to a publicly traded SPAC funded with $121.105 million of gross IPO and private placement proceeds, of which $115.575 million was placed in trust.
- No prior-period operating results or comparable financial statements are presented, and the filing does not identify material changes in revenue, profitability, margins, cash flow, or debt.
Agreements, Governance, Outlook, and Risks
- The company entered into underwriting, rights, letter, investment management trust, registration rights, administrative services, and business combination marketing agreements in connection with the IPO.
- John Joyce, Silvia Panigone, and Jian Zhang were appointed as independent directors. They were appointed to the audit, compensation, and nominating and corporate governance committees, with John Joyce serving as chair of each committee.
- The private placement units are substantially identical to the IPO units but generally cannot be transferred, assigned, or sold until 30 days after completion of the initial business combination.
- The filing does not provide a specific acquisition target, transaction guidance, earnings outlook, or forecast.
- The principal disclosed contingency is the requirement to redeem public shares if the company does not complete an initial business combination within 18 months after the IPO closing, subject to applicable law and the governing charter provisions.
Important Facts for Investors to Verify
- Verify the terms of the 18-month deadline, redemption rights, and permitted releases from the trust account.
- Review the underwriting agreement and business combination marketing agreement for fees, indemnities, and deferred compensation.
- Review the rights agreement to confirm the one-twentieth share entitlement and any anti-dilution or adjustment provisions.
- Assess dilution from the private placement units, rights, sponsor interests, and any future business combination financing.
- Confirm that the $115.575 million trust balance is before any applicable taxes, permitted withdrawals, transaction costs, or redemptions; the filing does not provide a detailed post-expense cash reconciliation.